Cargando…
T001: FDG-PET and serum TARC levels after one cycle of BV-AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET-response adapted EORTC-COBRA trial
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621543/ http://dx.doi.org/10.1097/01.HS9.0000890572.92604.2c |
| _version_ | 1784821581464207360 |
|---|---|
| author | Diepstra, Arjan Visser, Lydia Fortpied, Catherine Noordzij, Walter Loft, Annika Arens, Anne Sureda-Balari, Anna Carvalho, Susana Vranovský, Andrej Sents, Ward Buhrer, Emanuel Plattel, Wouter J. Hutchings, Martin |
| author_facet | Diepstra, Arjan Visser, Lydia Fortpied, Catherine Noordzij, Walter Loft, Annika Arens, Anne Sureda-Balari, Anna Carvalho, Susana Vranovský, Andrej Sents, Ward Buhrer, Emanuel Plattel, Wouter J. Hutchings, Martin |
| author_sort | Diepstra, Arjan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9621543 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96215432022-11-01 T001: FDG-PET and serum TARC levels after one cycle of BV-AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET-response adapted EORTC-COBRA trial Diepstra, Arjan Visser, Lydia Fortpied, Catherine Noordzij, Walter Loft, Annika Arens, Anne Sureda-Balari, Anna Carvalho, Susana Vranovský, Andrej Sents, Ward Buhrer, Emanuel Plattel, Wouter J. Hutchings, Martin Hemasphere Advanced Stages Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621543/ http://dx.doi.org/10.1097/01.HS9.0000890572.92604.2c Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Advanced Stages Diepstra, Arjan Visser, Lydia Fortpied, Catherine Noordzij, Walter Loft, Annika Arens, Anne Sureda-Balari, Anna Carvalho, Susana Vranovský, Andrej Sents, Ward Buhrer, Emanuel Plattel, Wouter J. Hutchings, Martin T001: FDG-PET and serum TARC levels after one cycle of BV-AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET-response adapted EORTC-COBRA trial |
| title | T001: FDG-PET and serum TARC levels after one cycle of BV-AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET-response adapted EORTC-COBRA trial |
| title_full | T001: FDG-PET and serum TARC levels after one cycle of BV-AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET-response adapted EORTC-COBRA trial |
| title_fullStr | T001: FDG-PET and serum TARC levels after one cycle of BV-AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET-response adapted EORTC-COBRA trial |
| title_full_unstemmed | T001: FDG-PET and serum TARC levels after one cycle of BV-AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET-response adapted EORTC-COBRA trial |
| title_short | T001: FDG-PET and serum TARC levels after one cycle of BV-AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET-response adapted EORTC-COBRA trial |
| title_sort | t001: fdg-pet and serum tarc levels after one cycle of bv-avd in advanced stage hodgkin lymphoma patients: results from the very early pet-response adapted eortc-cobra trial |
| topic | Advanced Stages |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621543/ http://dx.doi.org/10.1097/01.HS9.0000890572.92604.2c |
| work_keys_str_mv | AT diepstraarjan t001fdgpetandserumtarclevelsafteronecycleofbvavdinadvancedstagehodgkinlymphomapatientsresultsfromtheveryearlypetresponseadaptedeortccobratrial AT visserlydia t001fdgpetandserumtarclevelsafteronecycleofbvavdinadvancedstagehodgkinlymphomapatientsresultsfromtheveryearlypetresponseadaptedeortccobratrial AT fortpiedcatherine t001fdgpetandserumtarclevelsafteronecycleofbvavdinadvancedstagehodgkinlymphomapatientsresultsfromtheveryearlypetresponseadaptedeortccobratrial AT noordzijwalter t001fdgpetandserumtarclevelsafteronecycleofbvavdinadvancedstagehodgkinlymphomapatientsresultsfromtheveryearlypetresponseadaptedeortccobratrial AT loftannika t001fdgpetandserumtarclevelsafteronecycleofbvavdinadvancedstagehodgkinlymphomapatientsresultsfromtheveryearlypetresponseadaptedeortccobratrial AT arensanne t001fdgpetandserumtarclevelsafteronecycleofbvavdinadvancedstagehodgkinlymphomapatientsresultsfromtheveryearlypetresponseadaptedeortccobratrial AT suredabalarianna t001fdgpetandserumtarclevelsafteronecycleofbvavdinadvancedstagehodgkinlymphomapatientsresultsfromtheveryearlypetresponseadaptedeortccobratrial AT carvalhosusana t001fdgpetandserumtarclevelsafteronecycleofbvavdinadvancedstagehodgkinlymphomapatientsresultsfromtheveryearlypetresponseadaptedeortccobratrial AT vranovskyandrej t001fdgpetandserumtarclevelsafteronecycleofbvavdinadvancedstagehodgkinlymphomapatientsresultsfromtheveryearlypetresponseadaptedeortccobratrial AT sentsward t001fdgpetandserumtarclevelsafteronecycleofbvavdinadvancedstagehodgkinlymphomapatientsresultsfromtheveryearlypetresponseadaptedeortccobratrial AT buhreremanuel t001fdgpetandserumtarclevelsafteronecycleofbvavdinadvancedstagehodgkinlymphomapatientsresultsfromtheveryearlypetresponseadaptedeortccobratrial AT plattelwouterj t001fdgpetandserumtarclevelsafteronecycleofbvavdinadvancedstagehodgkinlymphomapatientsresultsfromtheveryearlypetresponseadaptedeortccobratrial AT hutchingsmartin t001fdgpetandserumtarclevelsafteronecycleofbvavdinadvancedstagehodgkinlymphomapatientsresultsfromtheveryearlypetresponseadaptedeortccobratrial |